持续葡萄糖监测对1型糖尿病肾移植受者血糖控制及心血管生化风险因素的影响
本研究比较了使用持续葡萄糖监测(CGM)的1型糖尿病肾移植受者(KTx CGM组,n=22)与同期胰肾联合移植(SPK组,n=22)患者在9-11年随访期间的心血管疾病生化风险因素。结果显示KTx CGM组空腹血糖和HbA1c较高,但CGM仍实现了良好的血糖控制并使部分心血管风险因素正常化;胰腺移植仍是实现生理性血糖水平的最佳手段。
要点
- CGM在1型糖尿病肾移植受者中可实现良好血糖控制并改善部分心血管生化风险因素。
- SPK组血糖控制(FPG、HbA1c)优于KTx CGM组,但两组血脂差异不大。
- KTx CGM组血清肌酐较高、eGFR较低,提示肾功能差异需关注。
核心结论
- 在1型糖尿病肾移植受者中应用CGM技术可实现良好的血糖控制,并使部分心血管疾病生化风险因素正常化。
- 胰腺移植仍是1型糖尿病肾移植受者实现生理性血糖水平的最佳手段。
研究设计与样本
- 研究纳入22例使用CGM的1型糖尿病肾移植受者(KTx CGM组)和22例1型糖尿病胰肾联合移植受者(SPK组)。
- 两组在移植时年龄、糖尿病病程、研究时年龄、性别、BMI、透析总时间、透析方式、移植前心血管疾病及再次肾移植率方面相匹配。
- 随访9-11年,评估血糖控制及心血管疾病风险的生化标志物。
主要发现
- KTx CGM组空腹血糖高于SPK组:6.5 [4.9; 7.8] vs 4.7 [4.4; 5.6] mmol/L,p<0.01。
- KTx CGM组HbA1c高于SPK组:6.7 [5.9; 7.5] vs 5.2 [5.1; 5.4]%,p<0.001。
- 两组总胆固醇和高密度脂蛋白无差异;KTx CGM组低密度脂蛋白较低(2.35 ± 0.66 vs 2.96 ± 1.13 mmol/L,p=0.056),甘油三酯较高(1.29 ± 0.45 vs 1.02 ± 0.39 mmol/L,p<0.05)。
- KTx CGM组血清肌酐较高(122.7 μmol/L vs 87.2 μmol/L,p<0.01),eGFR较低(73.8 ± 25.0 vs 51.3 ± 18.6 ml/min/1.73 m²,p<0.01)。
临床怎么用
- 对于1型糖尿病肾移植受者,CGM可作为改善血糖控制和心血管风险管理的有效工具。
- 临床需注意CGM组肾功能(肌酐、eGFR)较SPK组差,应个体化评估移植方式选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To compare biochemical risk factors for cardiovascular disease (CVD) in kidney transplant recipients (KTx) with type 1 diabetes (T1D) who used continuous glucose monitoring (CGM) devices or underwent simultaneous kidney and pancreas (SPK) transplantation during long-term follow-up. MATERIALS AND METHODS: 22 graft recipients with T1D using CGM (KTx CGM) and 22 patients with T1D after SPK were included in the study. Study groups were matched for age and diabetes duration at the time of transplantation, age at the time of the study, sex, body mass index (BMI), total duration of dialysis therapy, dialysis modality, pretransplant CVD, and rates of kidney re-transplantation. Biochemical markers of glycemic control and risk for CVD were assessed over a 9-11 year follow up period. RESULTS: Fasting plasma glucose (FPG) and HbA1c were higher in the KTx CGM versus SPK group (6.5 [4.9; 7.8] vs 4.7 [4.4; 5.6] mmol/L, p<0.01, and 6.7 [5.9; 7.5] vs 5.2 [5.1; 5.4]%, p<0.001, respectively). Total cholesterol (TC) and high-density lipoprotein (HDL) did not differ between groups. Low-density lipoprotein (LDL) concentrations were lower in the KTx CGM vs the SPK group (2.35 ± 0.66 vs 2.96 ± 1.13 mmol/L, p=0.056). Triglyceride values were higher in the KTx CGM vs SPK group (1.29 ± 0.45 mmol/L vs 1.02 ± 0.39 mmo/L, p<0.05). Serum creatinine was higher (122.7 μmol/L vs 87.2 μmol/L, p< 0.01), and estimated glomerular filtration rates (eGFR) were lower (73.8 ± 25.0 vs 51.3 ± 18.6 ml/min.1.73 m2, p< 0.01) in the KTx CGM vs the SPK group. CONCLUSIONS: Application of CGM technology in kidney graft recipients with T1D enabled good control of glucose levels and allowed for normalization of a number of biochemical risk factors for CVD. Pancreas transplantation remains the optimal procedure in achieving physiological blood glucose levels in T1D kidney recipients.
引用
- Widera M, Owczarek AJ, Kolonko A, et al. Impact of continuous glucose monitoring on glycemic control and biochemical cardiovascular risk factors in kidney transplant recipients with type 1 diabetes. Nephrol Dial Transplant. 2026. PMID: 42545755. doi:10.1093/ndt/gfag168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。